MSP
GILD icon

Madison Street Partners’s Gilead Sciences GILD Stock Holding History

Madison Street Partners’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-19,500
Closed -$1.84M – 39
2014
Q4 		$1.84M Buy
+19,500
New +$2.02M 2.84% 11

Other funds holding GILD

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Madison Street Partners's GILD Position: Q1 2015 in Review

Madison Street Partners sold out of Gilead Sciences (GILD) in Q1 2015, closing a stake of 19,500 shares — an estimated $1.84M sold.

Madison Street Partners first reported a position in GILD in Q4 2014 and held it in 1 quarter. The position peaked at $1.84M in Q4 2014. 1,492 funds tracked by Wall St. Rank hold GILD as of Q1 2015.

  • Madison Street Partners reported no remaining Gilead Sciences position as of Q1 2015 after selling out during the quarter.
  • Madison Street Partners sold 19,500 Gilead Sciences shares in Q1 2015, an estimated $1.84M.
  • Madison Street Partners first reported a position in Gilead Sciences in Q4 2014 and held it in 1 quarter.
  • Madison Street Partners's Gilead Sciences position peaked at $1.84M in Q4 2014.
  • 1,492 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2015.

Based on Madison Street Partners's 13F filing for Q1 2015, filed 11 May 2015.